Skip to Content

OP 150 (Lynparza 150 mg)

Generic Name: olaparib

Pill with imprint OP 150 is Green, Elliptical / Oval and has been identified as Lynparza 150 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Lynparza is used in the treatment of ovarian cancer; breast cancer, metastatic and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for OP 150

Lynparza

Generic Name:
olaparib
Imprint:
OP 150
Strength:
150 mg
Color:
Green
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
PARP inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC):
00310-0679

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide